Naphazoline Hydrochloride is the hydrochloride salt form of naphazoline, an imidazole derivative and a direct-acting sympathomimetic amine with vasoconstrictive properties. Upon ocular administration, naphazoline hydrochloride exerts its effect by acting on alpha-adrenergic receptors in the arterioles of the conjunctiva to produce vasoconstriction, resulting in decreased conjunctival congestion and diminished itching, irritation and redness. It is grouped under the following drug class(es): Alpha-2 agonists and Vasoconstrictors. Its therapeutic use is listed as decongestants. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Rhinantin, Rhinoperd, Stricylon and Niazol. Its PubChem CID is 11079.
Naphazoline hydrochloride
| CAS No | 550-99-2 |
|---|---|
| Molecular Formula | C14H15ClN2 |
| Molecular Weight | 246.73 g/mol |
| Synonyms | 2-(naphthalen-1-ylmethyl)-4,5-dihydro-1H-imidazole;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Naphazoline Hydrochloride is the hydrochloride salt form of naphazoline, an imidazole derivative and a direct-acting sympathomimetic amine with vasoconstrictive properties.
The listed CAS number is 550-99-2.
The listed molecular formula is C14H15ClN2.
The listed molecular weight is 246.73 g/mol.
2-(naphthalen-1-ylmethyl)-4,5-dihydro-1H-imidazole;hydrochloride.
The source lists Rhinantin, Rhinoperd, Stricylon and Niazol.